Interview – Xeltis brings bioabsorbable tech to heart valves
Clinical Design of ASAP-2 | tctmd.com
171114 XeltisSeries Release FINAL
Xeltis accelerating clinical trial program - Xeltis
Device and Clinical Trial Update: OneShot (Covidien) | tctmd.com
Brabant MedTech Coalition can give Xeltis an extra push forward - Innovation Origins
Xeltis initiates European first-in-human trial of restorative haemodialysis access graft - Renal Interventions
Xeltis Develops First Ever Bio-Absorbable Heart Valve
Frontiers | A Novel Restorative Pulmonary Valve Conduit: Early Outcomes of Two Clinical Trials | Cardiovascular Medicine
Xeltis | LinkedIn
EuroPCR 2017: Xeltis' Regenerated Heart Valve Shows Promising Early Preclinical Data :: Medtech Insight
Xeltis | LinkedIn
Xeltis AG - Product Pipeline Analysis, 2019 Update
Swiss medtech startup Xeltis raises €10.5 million to develop its novel tissue regeneration treatment for heart disease | EU-Startups
Frontiers | A Novel Restorative Pulmonary Valve Conduit: Early Outcomes of Two Clinical Trials | Cardiovascular Medicine
Xplore2 Trial Holding - Xplore 2 Trial
Title of Abstract
Xeltis BV | BioWorld
News - Xeltis
Xeltis initiates the first-ever pivotal trial of a synthetic restorative pulmonary heart valve - Innovation Origins
